One in two medical prescriptions issued in India deviate from standard guidelines: StudyA study in India found that almost half of medical prescriptions deviated from guidelines, with pantoprazole being commonly misprescribed. ...
Don’t pop that pill daily: Doctors red-flag proton pump inhibitors used to treat acid reflux, heartburnsThe reason for the popularity of PPIs among doctors and patients is not tough to gauge. With unhealthy lifestyles and dietary habits, acidi...
Why Torrent Pharma is ready to go ahead with the daunting Cipla dealAhmedabad-based Torrent Pharma is seeking financing for a deal with Indian pharmaceutical company Cipla. Torrent Pharma is interested in bu...
Costs of 127 medicines set to go down post NPPA's 5th price capAmong the 127 medications on the NPPA's list are paracetamol, amoxycillin, rabeprazole, and metformin. Patients frequently make use of many...
Drug pricing regulator fixes prices of 40 formulation drugsThe regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...
Wockhardt moves HC against ban on its fixed dose combination drugWockhardt moved the court as its anti-inflammatory drug -- Ace Proxyvon -- is one of the FDC medicines affected by the Centre's September 7...
Lupin launches generic GERD drug in the US marketUsed to treat gastroesophageal reflux disease.
Indian companies in FDA's first list for generic Aciphex tabletsIndian firms including Dr Reddy's, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic vers...
Cadila Pharma Chairman Indravadan Modi dies at 87Founder of Ahmedabad-based Cadila Pharmaceuticals, Indravadan Modi, better known as the octogenarian horse-riding chairman, passed away at ...
- Drug pricing by manufacturers, hospital retailers exploiting the consumer
The common man is pummelled by banking, insurance, real estate and other sectors, and by regulators. Health and pharma sectors can be added...
- IOL Chemicals plans Rabiprazole facility
IOL Chemicals and Pharmaceuticals plans to set up a manufacturing facility for Rabiprazole, an anti ulcer drug, at a capital expenditure of...
- Tokyo's Eisai to invest Rs 500 cr in Vizag SEZ
Tokyo-based pharma major Eisai has zoomed on India to set up a new Rs 500 crore manufacturing and R&D centre.
- Dr Reddy’s logs Rs 325-crore net profit in Q4
Hyderabad-Based Dr Reddy’s has crossed revenues of $1.5 billion or Rs 6,500 crore in 2006-07 against Rs 2,400 crore (FY06) piggybacking on ...
- DRL expects verdict in Aciphex case by May 15
As the patent clash between Dr Reddy's Labs (DRL) and Japanese pharma firm Eisai for the control over $1.3-billion anti-ulcer drug Aciphex ...
- Japanese drug major Eisai plans production in India
Japanese drug major Eisai Company, which has a marginal presence in India with just two products, will soon invest Rs 180 crore to start ma...